Global Peptide Therapeutics Market 2015-2017 & 2018-2027: Shifting Focus Toward Untapped Markets

DUBLIN, Aug. 7, 2018 /PRNewswire/ --

The "Global Peptide Therapeutics Market Analysis & Trends - Industry Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.

The Global Peptide Therapeutics Market is poised to grow strong during the forecast period 2017 to 2027

Some of the prominent trends that the market is witnessing include rising occurrences of cardiovascular illnesses technological enhancement with introduction of hybrid technology, shifting focus toward untapped markets and growth opportunities/investment opportunities.

This industry report analyzes the market estimates and forecasts of all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2015, 2016 revenue estimations are presented for 2017 and forecasts from 2018 till 2027.

The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies for the existing players, new entrants and the future investors.

Scope of the Report

• Based on technology, market is segmented into solid phase, liquid phase and hybrid phase.
• Depending on API peptide type, market is divided into CMO and in-house.
• By route of administration, market is classified into Oral, Parenteral, Pulmonary, Mucosal and Other Route of Administration.
• On basis of type, market is divided into generic and innovative.
• Among type of molecule, market is segmented into natriuretic, somatostatin, immunopeptide, vasopressin, calcitonin and other type of molecule.
• Based on application, market is classified into CNS, metabolic, renal, CVD, anti-infective, cancer, respiratory, dermatology, GIT, infectious disease and other applications.
• Other Applications segment is further sub-segmented into pain management and hematological disorders.

Key Topics Covered:

1 Market Outline

2 Executive Summary

3 Market Overview

4 Market, By Technology

5 Peptide Therapeutics Market, By API Peptide Type

6 Peptide Therapeutics Market, By Route of Administration

7 Peptide Therapeutics Market, By Type

8 Peptide Therapeutics Market, By Type of Molecule

9 Peptide Therapeutics Market, By Application

10 Peptide Therapeutics Market, By Geography

11 Key Player Activities

12 Leading Companies

• Amgen Inc.
• Takeda Pharmaceutical Company Limited
• Lonza Inc.
• AstraZeneca PLC
• Bristol-Myers Squibb(BMS)
• Pfizer Inc.
• Sanofi
• Teva Pharmaceutical
• Bachem Holding AG
• Eli Lilly and Company
• Novartis AG
• Glaxosmithkline (GSK)
• Novo Nordisk A/S

For more information about this report visit https://www.researchandmarkets.com/research/rbnlv7/global_peptide?w=5

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/global-peptide-therapeutics-market-2015-2017--2018-2027-shifting-focus-toward-untapped-markets-300693333.html

SOURCE Research and Markets